tbuckley/cabot-search huggingface dataset:
Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host &amp; Viral Analysis of Post-Transplant Lymphoproliferative Disorders
Authors: Joseph Schroers-Martin, Andrea Garofalo, Joanne Soo, Jan Boegeholz, Stefan K. Alig, Brian Sworder, Chih Long Liu, Helen Luikart, Gerardo Gamino, DP Morales, Kathrin Freystätter, James Hamilton, David M. Kurtz, Seth Hollander, David Rosenthal, Gundeep Dhillon, Jayant Raikhelkar, Stijn Verleden, Marcel Nijland, Sean Agbor-Enoh, Martin Andreas, Abdallah Kfoury, Heather Ross, Lorenzo Zaffiri, Yasodha Natkunam, Maximilian Diehn, Kiran Khush, Ash A. Alizadeh
Journal: Blood (2022)
Circulating Clonal Plasma Cells at Diagnosis and Peripheral Blood Measurable Residual Disease Assessment Provide Powerful Prognostication Biomarkers in Newly-Diagnosed Multiple Myeloma Patients Treated without Autologous Transplant
Authors: Prashant Ramesh Tembhare, Harshini Sriram, Twinkle Khanka, Sanghamitra Gawai, Sitaram Ghogale, Nilesh Deshpande, Bhausaheb Bagal, Gaurav Chatterjee, Syed Khizer Hasan, Sweta Rajpal, Nikhil Patkar, Hasmukh Jain, Dhanlaxmi Lalit Shetty, Kinjalka Ghosh, Nitin Inamdar, Sachin Punatar, Anant Gokarn, Manju Sengar, Navin Khattry, Papagudi Ganesan Subramanian, Sumeet Gujral
Journal: Blood (2022)
Immunotherapy By Targeting CD45 in Mismatched HLA-DP to Treat Patients after Allogeneic Stem Cell Transplantation
Authors: Nadine E. Struckman, Sebastian Klobuch, Michel G.D. Kester, Wendy de Klerk, Arnoud H. de Ru, Mirjam H.M. Heemskerk, Peter A. van Veelen, Peter van Balen, J.H.Frederik Falkenburg, Marieke Griffioen
Journal: Blood (2022)
Perioperative Monitoring with Global Coagulation Test in Severe Hemophilia a without Inhibitor on Emicizumab Prophylaxis Undergoing Orthopedic Surgery
Authors: Abel Dos Santos Ortas, Jose Manuel Martin de Bustamante Gonzalez-Iglesias, Maria Isabel Perez Vaquero, Maria Teresa Alvarez Roman, María Isabel Rivas Pollmar, Mónica Martín Salces, Eduardo Garcia Perez, Mar Gutierrez, Elena G Arias-Salgado, Nora V. Butta, Paula Acuña, Elena Monzón Manzano, Cédric Hermans, Víctor Jiménez-Yuste
Journal: Blood (2022)
In Multiple Myeloma Patients without Known Cytogenetic Risk Features, Genomic Features Contribute to Early Death Risk at Diagnosis
Authors: Anil Aktas-Samur, Jill Corre, Laure Buisson, Mariateresa Fulciniti, Kenneth C. Anderson, Mehmet K. Samur, Nikhil C Munshi, Herve Avet-Loiseau
Journal: Blood (2022)
Proteomic and Lipidomic Investigation of an Ex-Vivo Human Model of Sickle Cell Disease Erythropoiesis and Patient Erythrocytes Reveals the Abnormal Localization and Dysfunction of the Proteasome, Disrupted Antioxidant Defenses and Altered Lipid Profiles
Authors: Julien Delobel, Romain Hamelin, Viviane Praz, Hector Gallart-Ayala, Florence Armand, Manfredo Quadroni, Katia Balmas-Bourloud, Diego Chiappe, Carlo Brugnara, Julijana Ivanisevic, Raffaele Renella
Journal: Blood (2022)
Diagnostic Utility of Whole Genome Sequencing in Adults with B-Other Acute Lymphoblastic Leukaemia
Authors: Daniel Leongamornlert, Jesús Gutiérrez-Abril, SooWah Lee, Emilio Barretta, Thomas Creasey, Krisztina Zuborne Alapi, Max F. Levine, Juan E Arango-Ossa, Juan S Medina-Martinez, Amy A. Kirkwood, Laura Clifton-Hadley, Pip Patrick, David Jones, Adam P Butler, Christine J. Harrison, Peter J. Campbell, Bela Patel Wrench, Anthony V. Moorman, Adele K. Fielding, Elli Papaemmanuil
Journal: Blood (2022)
The Marine Product Elatol Is a Novel Inhibitor of Mitochondrial Translation Triggering the Integrated Stress Response and Apoptosis in Leukemia and Lymphoma Cells
Authors: Tyler A. Cunningham, Priyanka Maiti, Paola Manara, Vivek Singh, Nigel Beaton, Alexey Amunts, Flavia Fontanesi, Antonio Barrientos, Jonathan H. Schatz
Journal: Blood (2022)
Prolonged Combinatorial Pharmacological Therapy Targeting the Epigenome Increases Fetal Hemoglobin to Clinically Relevant Levels in Normal, Nonanemic Baboons
Authors: Vinzon Ibanez, Kestis Vaitkus, Robert E. Molokie, Jagadeesh Ramasamy, Yogenthiran Saunthararajah, Donald Lavelle
Journal: Blood (2022)
A Multicenter, Single-Arm, Prospective Phase II Study of Orelabrutinib Combined with High-Dose Methotrexate and Rituximab Sequential Autologous Hematopoietic Stem Cell Transplantation in Newly-Dignosed Primary Central Nervous System Lymphoma
Authors: Ji Ma, Qiang He, Ke Lu, Liang Wang
Journal: Blood (2022)
Impact of Early Hospitalization, Medical Comorbidities and Allogeneic Stem Cell Transplantation on Survival in Acute Myeloid Leukemia Patients Treated with Venetoclax Based Therapy - a Single Institution Experience from an Academic Center
Authors: Emma E Williams, Danielle McQuinn, Lauren G. Banaszak, Cameron Ninos, Ryan J. Mattison, Zhubin Gahvari, Aric C. Hall, Michael J Fallon, Kalyan VG Nadiminti
Journal: Blood (2022)
MAF Translocations Are Enriched in NDMM Patients with Elevated Levels of Circulating Tumor Cells Suggesting a Genetic Basis for Aggressive Disease Course
Authors: Cathelijne Fokkema, Madelon M.E. de Jong, Sabrin Tahri, Davine Hofste Op Bruinink, Zoltan Kellermayer, Chelsea den Hollander, Michael Vermeulen, Natalie Papazian, Mark van Duin, Remco Hoogenboezem, Michiel J.W. Wevers, Vincent H.J. van der Velden, Mathijs A. Sanders, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
Journal: Blood (2022)
Lower-Intensity CPX-351 + Venetoclax for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy: <i>Post Hoc</i> Analysis By Disease Risk Subgroups
Authors: Tara L. Lin, Praneeth Baratam, Robert K. Stuart, Roland B. Walter, Eric S. Winer, Stefan Faderl, Vijayalakshmi Chandrasekaran, Divya Chakravarthy, Ronald S. Cheung, Vinod A. Pullarkat
Journal: Blood (2022)
Ex Vivo Generation and Infusion of Anti-Minor Histocompatibility Antigen Expanded T Cells for Patients Who Relapse after Allogeneic HLA-Matched Stem Cell Transplantation
Authors: Denis-Claude Roy, Jean-Sébastien Delisle, Imran Ahmad, Brian Leber, Félix Couture, Stephanie Thiant, Natasha Kekre, Radia Sidi Boumedine, Cédric Carli, Ann Brasey, Nadia M. Bambace, Léa Bernard, Sandra Cohen, Thomas L. Kiss, Jean Roy, Guy Sauvageau, Olivier Veilleux, Claude Perreault, Lambert Busque, Silvy Lachance
Journal: Blood (2022)
Monitoring Plasma Cells and Clonal Emergence through Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma
Authors: Ankit K. Dutta, Jean-Baptiste Alberge, Elizabeth D. Lightbody, Cody J. Boehner, Romanos Sklavenitis-Pistofidis, Amanda Cao, Tarek H. Mouhieddine, Anna Cowan, Nang Kham Su, Andrew Dunford, Erica Horowitz, Hadley Barr, Jenna B. Beckwith, Laura Hevenor, Jacqueline Perry, Ornkleaw Zepp, Thai Bui, Steven Gross, Omar Nadeem, Chip Stewart, Daniel Auclair, Gad Getz, Irene Ghobrial
Journal: Blood (2022)
Novel Chemical Series of Anti-ST2 Small Molecules Suppress Allogeneic T Cells Proliferation While Increasing Treg Cells and Improve Gvhd and Survival In Vivo
Authors: Chao-Yie Yang, Xinrui Yuan, Hua Jiang, Jason C. Rech, Denggang Fu, Aaron Robida, Krishani Rajanayake, Hebao Yuan, Bo Wen, Duxin Sun, Krishnapriya Chinnaswamy, Jeanne A. Stuckey, Sophie Paczesny
Journal: Blood (2022)
Compound Nanoparticle 5HMF-Prodrug Formulations for Optimized Anti-Sickling Therapy
Authors: Stephen C Rogers, Parikshit Moitra, Mary Brummet, Zohreh Safari, Qihong Wang, Joy Okhuevbie, Nancy Anabaraonye, Osheiza Y. Abdulmalik, Martin K. Safo, Nicole Glynn-Cunningham, Jennie Y. Law, Maria R. Baer, Dipanjan Pan, Allan Doctor
Journal: Blood (2022)
Comparative Analysis of Genome-Scale Gene Regulatory Networks in Human Hematopoietic Stem and Myeloid Progenitor Fractions
Authors: Shruthi Subramanian, Julie A.I. Thoms, Yizhou Huang, Sebastien Jacquelin, Sylvie Shen, Emma Song, Swapna Joshi, Chris Brownlee, Petter S Woll, Diego Chacon Fajardo, Dominik Beck, David J. Curtis, Kenneth Yehson, Vicki Antonenas, Tracey O' Brien, Annette Trickett, Jason Powell, Stuart M Pitson, Maher K. Gandhi, Paola Cornejo, Emily Wong, Steven W Lane, Bertie Gottgens, Hamid Alinejad Rokny, Jason W.H Wong, John E. Pimanda
Journal: Blood (2022)
Clinical Development of <i>Senza5TM CART5:</i> a Novel Dual Population CD5 CRISPR-Cas9 Knocked out Anti-CD5 Chimeric Antigen Receptor T Cell Product for Relapsed and Refractory CD5+ Nodal T-Cell Lymphomas
Authors: Ruchi P. Patel, Guido Ghilardi, Patrizia Porazzi, Steven Yang, Dean Qian, Raymone Pajarillo, Michael Wang, Yunlin Zhang, Stephen J. Schuster, Stefan K. Barta, Aditya Nimmagadda, Adam Snook, Nicholas A. Siciliano, Marco Ruella
Journal: Blood (2022)
Pembrolizumab in Combination with Epigenetic Therapy Is Safe and Active in Heavily Treated Patients with Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL): Preliminary Results from the Embolden Trial
Authors: Nathan Roberts, John Lister, N. Nora Bennani, Salvia Jain, Tammy Battaglia, Emily C. Ayers, Craig A. Portell, Michael E. Williams, Prem Batchala, Ipsita Pal, Owen A. O'Connor, John Sanil Manavalan, Enrica Marchi
Journal: Blood (2022)
Clinical Laboratory Mutation Analysis Performed on Tumor Biopsies from Patients with Relapsed/Refractory Aggressive B Cell Lymphoma Treated with Palliative-Intent Therapy
Authors: Danielle F Soberman, Jennifer J.D. Morrissette, Stephen J. Schuster, Sunita Dwivedy Nasta, James N. Gerson, Stefan K. Barta, Jakub Svoboda, Elise A. Chong, Megan S. Lim, Daniel J. Landsburg
Journal: Blood (2022)
Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation
Authors: Alexandros Spyridonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles Craddock, Eva Maria Wagner, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus Kröger, Victoria Potter, Edouard Forcade, Jakob Passweg, Régis Peffault de Latour, Johan Maertens, Keith Wilson, Jean-Henri Bourhis, Bipin Savani, Fabio Ciceri, Arnon Nagler, Mohamad Mohty
Journal: Blood (2022)
First-Mind: Final Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Authors: Grzegorz S. Nowakowski, Johannes Duell, Katerina Kopeckova, Marek Trneny, Christiane Pott, Mouhamad Khouja, John M. Burke, Maeve Waldron-Lynch, Steve Wagner, Amitava Mukhopadhyay, Derek Blair, David Belada
Journal: Blood (2022)
Comprehensive Age-Stratified Impact of <i>NPM1</i> Mutation in Acute Myeloid Leukemia
Authors: Abdul Moiz Khan, Sushmitha Nanja Reddy, Mai M M Aly, Vikram Dhillon, Ali Al Sbihi, Tariq Kewan, Waled Bahaj, Carmelo Gurnari, Bayan Al-Share, Gregory Dyson, Valeria Visconte, Suresh Kumar Balasubramanian
Journal: Blood (2022)
DC-SIGN Binding to the Oligomannose-Type Glycans on the Surface Immunoglobulin Variable Region of Follicular Lymphoma Promotes Selective Adhesion to Microenvironmental VCAM-1
Authors: Giorgia Chiodin, Dylan Tatterton, Patrick J Duriez, Ayse Ertay, Philip J Rock, Benjamin Sale, Stuart Lanham, Luis Del Rio, Carl Figdor, Richard Burack, Freda K Stevenson, Francesco Forconi
Journal: Blood (2022)
Prognostic Analysis According to European Leukemianet 2022 Risk Stratification for Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine
Authors: Mihee Kim, Taehyung Simon Kim, Seo-Yeon Ahn, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Seunghyun Choi, MiYeon Kim, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Kim
Journal: Blood (2022)
Single-Agent Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma: Final Analysis of the DREAMM-2 Trial
Authors: Ajay K. Nooka, Adam Cohen, Hans C. Lee, Ashraf Z. Badros, Attaya Suvannasankha, Natalie Callander, Al-Ola Abdallah, Suzanne Trudel, Ajai Chari, Edward Libby, Maria Chaudhry, Malin Hultcrantz, Martin Kortuem, Paul G. Richardson, Rakesh Popat, Douglas W. Sborov, Shawn Hakim, Eric Lewis, Bharat Bhushan, Boris Gorsh, Ira Gupta, Joanna Opalinska, Sagar Lonial
Journal: Blood (2022)
ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine
Authors: Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo, Brian A. Jonas, Vinod A. Pullarkat, Michael J. Thirman, Christian Recher, Andre C. Schuh, Sunil Babu, Monique Dail, Grace Ku, Yan Sun, Jalaja Potluri, Brenda Chyla, Daniel A. Pollyea
Journal: Blood (2022)
The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Authors: Jianai Sun, Yi Xu, Min Yang, Huafeng Wang, Wenjuan Yu, Liangshun You, Haitao Meng, Chunmei Yang, Xinping Zhou, Li Li, De Zhou, Xiujing Ye, Hong-hu Zhu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood (2022)
Combination Anti-PD1 Antibody and Rituximab Followed By R-CHOP for Elderly Patients with Newly Diagnosed DLBCL: Analysis of the Phase II TREND Trial
Authors: Gao Yan, Xiaoxiao Wang, Bing Bai, Xue-Ping Li, Suxia Lin, Yanxia He, Liqin Ping, Cheng Huang, Jibin Li, Jiaying Mao, Huiqiang Huang
Journal: Blood (2022)
Real World Data on Unique Challenges and Outcomes of Older Patients with AML from Resource Limited Settings: Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)
Authors: Suvir Singh, Sharon Lionel, Hasmukh Jain, Lingaraj Nayak, Sushil Selvarajan, Prasanna Samuel, Rayaz Ahmed, Narendra Agrawal, Pavitra DS, Poojitha Byreddy, Joseph M John, Kundan Mishra, Suman Kumar, Mobin Paul, Latha Abraham, Smita Kayal, Prasanth Ganesan, Chepsy C Philip, Damodar Das, Sreeraj Vasudevan, Prashant Mehta, Jayachandran PK, Vineetha Raghavan, Stalin Chowdary Bala, Bharath Ram S, Swaratika Majumdar, Akhil Rajendra, Om Prakash, Barath U, Bhausaheb Bagal, Aby Abraham, Rajan Kapoor, Dinesh Bhurani, Manju Sengar, Vikram Mathews
Journal: Blood (2022)
Early Effects of a Repurposed Therapeutic PB-04 in Beta Thalassemia Intermedia and in Transgenic Sickle Mice
Authors: Betty S. Pace, Seyed Mehdi Nouraie, Kevin H.M. Kuo, Sylvia Singer, Mayuko Takezaki, Biaoru Li, Aidan D Faller, Abdullah Kutlar, Susan P Perrine
Journal: Blood (2022)
Combination of Cytogenetic Classification and MRD Status Correlates with Outcomes of Autologous Versus Allogeneic Stem Cell Transplantation in Adults with B Cell-Acute Lymphoblastic Leukemia in First Remission
Authors: Rongli Zhang, Mengnan Lyu, Yi He, Donglin Yang, Aiming Pang, Jialin Wei, Qiaoling Ma, Weihua Zhai, Xin Chen, Guixin Zhang, Sizhou Feng, Mingzhe Han, Erlie Jiang
Journal: Blood (2022)
Recent Bendamustine Treatment before Apheresis Has a Negative Impact on Outcomes in Patients with Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
Authors: Gloria Iacoboni, ANA Africa Martin Lopez, Katarzyna Aleksandra Jalowiec, Mi Kwon, Kai Rejeski, Víctor Navarro Garcés, Paula Amat, Juan Luis Reguera, Laura Gallur, Sara Gutierrez-Herrero, Claire Roddie, Gillen Oarbeascoa, Ana Benzaquén, Cecilia Carpio, Lucía López Corral, Rafael Hernani, Mariana Bastos-Oreiro, Marion Subklewe, Maeve O'Reilly, Lourdes Martín, Pere Barba
Journal: Blood (2022)
Deep Peripheral T Cell Immune-Profiling in Relapsed/Refractory Non-Hodgkin Lymphoma: Evaluation of Baseline Samples from the Epcoritamab Epcore NHL-1 Trial
Authors: Jordan Blum, Gregg Masters, Christopher Chiu, Han Si, Jeremy Gale, Lisa Grimm, Manling Ma-Edmonds, Matthew Loya, Mahesh Bachu, Omar Jabado, David Soong, Jimin Zhang, Monica Wielgos-Bonvallet, Nicole Bottrel, Erin Henitz, Brandon Higgs, Kate Sasser, Maria Jure-Kunkel, Mark Fereshteh
Journal: Blood (2022)
Efficient and Specific Multi-Locus Editing of Allogeneic CAR T Cells for Hypoimmunity during Large Scale Manufacture Using Cas12b
Authors: Christina Chaivorapol, Pascal Beauchesne, Rowena De Jesus, William E Dowdle, Xiaoyu Chen, Alison Bayley, Yunjiang Qiu, Andrew Birnberg, Yu Zheng, Antonino Montalbano, Angela Liu, Misbah Zafar, Karl Manner, Ramya Ankala, Eleonore Tham, Heer Shah, Ben Lam, Jaclyn Lock, Lindong Weng, Kate Watts, Amanda Valdiosera, Kimberly Davis, Lei Wang, Divy Kangeyan, PhD, Nicolas Devos, Athena Wong, Jason Lih, Edward J Rebar
Journal: Blood (2022)
Domiciliary Nursing Management for Patients Affected By Multiple Myeloma during Covid-19 Pandemia in the Viterbo Home Care Unit: Data Analysis from March 2020 to March 2022
Authors: Elisa Emanueli Cippitelli, Vincenza Innocenti, Gioia De Angelis, Silvia Bertelli, Roberta Talucci, Roberta Perazzini, Roberta Burla, Valentina Panichi, Giuseppe Topini, Ambra Di Veroli, Alessia Fiorini, Caterina Mercanti, Fiammetta Natalino, Caterina Stefanizzi, Cinzia De Gregoris, Michela Tarnani, Marco Morucci, Cristina Mastino, Giulio Trapè, Marco Montanaro, Roberto Latagliata, Silvia Ciambella
Journal: Blood (2022)
Phase I Study of Tagraxofusp with or without Chemotherapy in Pediatric Patients with Relapsed or Refractory CD123-Expressing Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium Trial
Authors: Adam J. Lamble, Yueh-Yun Chi, Bill H. Chang, Anupam Verma, Kelly E Faulk, Alexandra McLean Stevens, Lauren Pommert, Sarah Tucker, Benjamin Brookhart, Nirali N. Shah, Christopher L. Brooks, Tariq I. Mughal, Alan S. Wayne, Soheil Meshinchi, Todd M. Cooper
Journal: Blood (2022)
Oral SGLT2 Inhibitors in Glycogen Storage Disease Type Ib and G6PC3-Deficiency. Preliminary Results from an Off-Label Study of 21 Patients
Authors: Jean Donadieu, Aurelia Alimi, Anais Brassier, Blandine Beaupain, Camille Wicker, jean-Meidi Alili, Christine Bellanne-Chantelot, Amelie Chaussade, Martin Castelle, Mathlide Lamarque, Isabelle Plo, Lea Durix, Aude Pion, Sylvie Souquere, Caroline Marty, Pierre Simon Rohrlich, Karine Mention, Wadih Abouchahla, Marie Szymanowski, Myriam Dao, Felipe Suarez, Paola Parronchi, Boaz Palterer, Noemie Urvoy, Hélène Lapillonne, Fabrizio Andreelli, Emile Van Schaftingen, Philippe Labrune, Pascale De Lonlay, Maria Veiga Da Cunha
Journal: Blood (2022)
A Phase 2 Study of Ruxolitinib with Chemotherapy in Children with Philadelphia Chromosome-like Acute Lymphoblastic Leukemia (AALL1521/INCB18424-269): Biologic Characteristics and Minimal Residual Disease Response of Patients with Non-<i>CRLF2</i>-Rearranged JAK Pathway Alterations
Authors: Sarah K Tasian, Deborah S Hunter, I-Ming L Chen, Richard C Harvey, Andrew J. Carroll, Elizabeth Wagner, Shalini C Reshmi, Michael J Borowitz, Brent L. Wood, Jeannie Daniel, Meenakshi Devidas, Elizabeth A. Raetz, Stephen P. Hunger, Albert Assad, Mignon L. Loh
Journal: Blood (2022)
Variable Immune Response Following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Patients with Hematological Malignancies Under Treatment
Authors: Juliëtte Schmidt, Peter M. Hoogerbrugge, Caroline Lindemans, Stefan Nierkens, Robert S. Van Binnendijk, Louis J Bont, Wim J.E. Tissing
Journal: Blood (2022)
What Is the Benefit of Autologous Stem Cell Transplantation in Multiple Myeloma Beyond the Age of 65? Inputs from Real-World Data in the Emmy Cohort
Authors: Aurore Perrot, Olivier Decaux, Bruno Royer, Denis Caillot, Karim Belhadj Merzoug, Agathe Farge, Laurent Frenzel, Cécile Sonntag, Bohrane Slama, Emmanuelle Bourgeois-Petit, Philippe Moreau, Laurent Voillat, Odile Luycx, Lotfi Benboubker, Gian-Matteo Pica, Frederic Maloisel, Jean-Richard Eveillard, Caroline Algrin, Anna Schmitt, Ronan Garlantézec, Nathalie Texier, Raphael Germain, Marion Willaime, Cyrille Hulin
Journal: Blood (2022)
C1 Inhibitor Deficiency Results in Increased Activation of Coagulation and Enhanced Venous Thrombosis
Authors: Steven P. Grover, Tomohiro Kawano, Linda Sundler Bjorkman, Francesco P. Giorgino, Sophia Dhrolia, Rohan Kasthuri, Sigrid Braekkan, Zsofia Polai, Henriette Farkas, Arne Egesten, John-Bjarne Hansen, Nigel Mackman
Journal: Blood (2022)
Treatment Patterns and Survival of Patients with Relapsed and Refractory Classical Hodgkin Lymphoma in Latin America
Authors: Seisha Alana Von Glasenapp Gossen, Humberto Martinez-Cordero, Luis Villela, Perla Rocio Colunga-Pedraza, Fernando Perez-Jacobo, Arianna Robles, Diego Fernando Garces PAZ, Henry Idrobo, Denisse Castro, Sally Rose Paredes, Brady E Beltran, Ana Carolina Oliver, Victoria Irigoin, Juan Alejandro Ospina, Rosa Oliday Rios
Journal: Blood (2022)
Immune Checkpoints Involving the PD-1/PD-L1/L2 and CD73/A2aR Axes and the Immunosuppressive Microenvironment in DLBCL
Authors: Xianhuo Wang, Tingting Zhang, Hengqi Liu, Sicong Zhang, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Kai Fu, Huilai Zhang
Journal: Blood (2022)
MYD88 L265P Mutation and Other Variants Show Different Molecular Characteristics in Diffuse Large B-Cell Lymphoma Treated with R-CHOP in China
Authors: Yan Qin, Tian Qiu, Zucheng Xie, Peng Liu, Jianliang Yang, Xiaohui He, Lin Gui, Shengyu Zhou, Hongxin Jiang, Changgong Zhang, Sheng Yang, Le Tang, Yuankai Shi
Journal: Blood (2022)
Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Versus R-GDP
Authors: Douglas A. Stewart, Lois E. Shepherd, Jill J. Dudebout, Jean-François Larouche, Neil Chua, Tara Baetz, Michael Crump, Mona Shafey, Nizar Abdel-Samad, Sue Robinson, Isabelle Fleury, Deborah Marcellus, Pamela Skrabek, Jesse Kelly, Annette E. Hay, Bingshu Chen, John Kuruvilla
Journal: Blood (2022)
Outcomes of Subsequent Anti-Lymphoma Therapies in Patients (Pts) with Large B-Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel (Axi-Cel) or Standard of Care (SOC) in the Second-Line (2L) ZUMA-7 Study
Authors: Armin Ghobadi, Javier Munoz, Jason Westin, Frederick L. Locke, David B. Miklos, Aaron P. Rapoport, Miguel-Angel Perales, Patrick M. Reagan, Joseph P. McGuirk, Caron A. Jacobson, Marie José Kersten, Irit Avivi, Andrew Peng, Marco Schupp, Christina To, Olalekan O. Oluwole
Journal: Blood (2022)
Preliminary Data from the Phase I/II Study of TP-3654, a Selective Oral PIM1 Kinase Inhibitor, in Patients with Myelofibrosis Previously Treated with or Ineligible for JAK Inhibitor Therapy
Authors: Firas El Chaer, James McCloskey, Lindsay A.M. Rein, Randy A. Brown, Steven D. Green, Jeffrey J. Pu, Shuichi Shirane, Kazuya Shimoda, Michiko Ichii, Junichiro Yuda, Joseph Scandura, Sujan Kabir, Jason M Foulks, Jian Mei, Huyuan Yang, Mark Wade, Carl Stapinski, Claudia Lebedinsky, Raajit K Rampal
Journal: Blood (2022)
Multi-Omics Profiling of Skin Biopsies of Patients with Sclerodermatous Graft-Vs-Host Disease Suggests Therapeutic Potential of Targeting Don't Eat Me Signals
Authors: Lu Cui, Cristabelle De Souza, Tristan Lerbs, Jessica Poyser, Clarissa Yu, Kerri Rieger, Sally Arai, Ryanne Brown, Judith A Shizuru, Antonia Maria Susanne Müller, Gerlinde Wernig
Journal: Blood (2022)
Evaluation of Infection in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Systematic Review
Authors: Anna R. Blankstein, Neelan Sriranjan, Nora Choi, Kristjan Paulson, David Sanford, Lee Mozessohn, Donald S. Houston, Emily Rimmer, Sylvain Lother, Asher Mendelson, Allan Garland, Rena Buckstein, Annette E. Hay, Ryan Zarychanski, Brett L. Houston
Journal: Blood (2022)
Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported Outcomes
Authors: Jessie L Barnum, Kathryn Torok, Franziska Rosser, Nicole Hogue, Shawna Mcintyre, Haley Havrilla, Vickie Vandergrift, Kirsten Rose-Felker, Vibha Sood, Adam Olson, Paul Szabolcs
Journal: Blood (2022)
Splicing Gene Mutations Do Not Affect Outcomes in Newly Diagnosed Patients with Acute Myeloid Leukemia
Authors: Jayastu Senapati, Nicholas Short, Abhishek Maiti, Hussein A Abbas, Naval Daver, Naveen Pemmaraju, Sherry A. Pierce, Kelly S. Chien, Koji Sasaki, Danielle Hammond, Gautam Borthakur, Farhad Ravandi, Hagop Kantarjian, Courtney D. DiNardo
Journal: Blood (2022)